Search results for "Antiplatelet therapy"


 
Results 1 - 10 of about 58 for "Antiplatelet therapy".

Did you mean "antiplatelet agents"?

Sort by: Relevance | Newest | Oldest

Three months after PCI, discontinuing aspirin associated with less bleeding than continued dual antiplatelet therapy

High-risk patients who were randomized to switch to ticagrelor plus placebo had similar rates of cardiovascular events as those who continued ticagrelor plus aspirin, an industry-funded trial found.
https://immattersacp.org/weekly/archives/2019/10/08/2.htm
8 Oct 2019

Parsing periop predicaments

Due to a lack of evidence for best perioperative procedures, clinicians have debated for decades how to address circumstances such as stroke or atrial fibrillation.
https://immattersacp.org/archives/2024/07/parsing-periop-predicaments.htm
1 Jul 2024

New recommendations released on primary prevention of stroke

The updated guideline from the American Heart Association and American Stroke Association addresses lifelong stroke prevention and includes new sex-and gender-specific recommendations.
https://immattersacp.org/weekly/archives/2024/10/29/1.htm
29 Oct 2024

Warnings on long-term dual antiplatelet therapy, more

This update covers the recall of rapid gram-negative combo panels, approval of an extended-release opioid analgesic, and a new rule about labeling prescription drugs related to pregnancy and lactation.
https://immattersacp.org/archives/2015/02/fda.htm
1 Feb 2015

Trial of apixaban with single and combination antiplatelet therapy in ACS stopped early due to observed increase in major bleeding events

Full-dose anticoagulation, in combination with antiplatelet therapy of any kind in patients with acute coronary syndrome, results in substantial bleeding without any clear additional benefit and should only be considered when required for another condition.
https://immattersacp.org/weekly/archives/2015/08/11/4.htm
11 Aug 2015

New guidelines for dual antiplatelet therapy in patients with CAD

Clinicians should weigh ischemic risks and bleeding risks before adding a P2Y12 inhibitor to aspirin monotherapy or prolonging dual antiplatelet therapy, among other recommendations.
https://immattersacp.org/weekly/archives/2016/04/05/2.htm
5 Apr 2016

Take TIAs as seriously as a stroke

Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://immattersacp.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023

New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy

New-generation anticoagulants are associated with increased bleeding risk when used after acute coronary syndrome (ACS) in patients taking antiplatelet agents, according to a new meta-analysis.
https://immattersacp.org/weekly/archives/2012/10/02/5.htm
2 Oct 2012

Take a team approach to coronary disease

A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024

Study of DAPT after TIA or minor stroke finds high-risk subgroup benefits more, has higher bleeding rates

The absolute but not the relative efficacy of dual antiplatelet therapy (DAPT) over aspirin varied by stroke risk among patients who had already had a transient ischemic attack (TIA) or minor ischemic stroke.
https://immattersacp.org/weekly/archives/2024/01/09/2.htm
9 Jan 2024

Result Page: Prev   1   2   3   4   5   6   Next